These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 38166811)
1. Cut-off value for interleukin-34 as an additional potential inflammatory biomarker for estimation of slow coronary flow risk. Karasu M; Bolayır HA BMC Cardiovasc Disord; 2024 Jan; 24(1):2. PubMed ID: 38166811 [TBL] [Abstract][Full Text] [Related]
2. Increased plasma high-sensitivity C-reactive protein and myeloperoxidase levels may predict ischemia during myocardial perfusion imaging in slow coronary flow. Yurtdaş M; Yaylali YT; Kaya Y; Ozdemir M Arch Med Res; 2014 Jan; 45(1):63-9. PubMed ID: 24316393 [TBL] [Abstract][Full Text] [Related]
3. Assessment of risk factors and left ventricular function in patients with slow coronary flow. Li Y; Wang Y; Jia D; Lv Y; Zhang Y; Guan Z; Ma C Heart Vessels; 2016 Mar; 31(3):288-97. PubMed ID: 25475386 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-10 promotor -592A/C polymorphism is associated with slow coronary flow in Han Chinese. Shi GL; Cai XX; Su YM; Chen C; Deng XT; Pan HY; Fan MK; Zhu JH; Pan M Int J Clin Exp Pathol; 2015; 8(4):4091-8. PubMed ID: 26097597 [TBL] [Abstract][Full Text] [Related]
5. Increased mean platelet volume in patients with slow coronary flow. Sen N; Basar N; Maden O; Ozcan F; Ozlu MF; Gungor O; Cagli K; Erbay AR; Balbay Y Platelets; 2009 Feb; 20(1):23-8. PubMed ID: 19172518 [TBL] [Abstract][Full Text] [Related]
6. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon. Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937 [TBL] [Abstract][Full Text] [Related]
7. [Can biomarkers help us to understand the pathogenesis of coronary slow flow? Endocan and omentin-I in slow coronary flow phenomenon]. Sığırcı S; Sarıkaya R; Keskin K; Yıldız SS; Pilten Güzel S; Çetinkal G; Önur İ; Kılıçkesmez KO Turk Kardiyol Dern Ars; 2019 Jun; 47(4):251-257. PubMed ID: 31219439 [TBL] [Abstract][Full Text] [Related]
8. Association of paraoxonase activity and coronary blood flow. Yildiz A; Gur M; Yilmaz R; Demirbag R; Polat M; Selek S; Celik H; Erel O Atherosclerosis; 2008 Mar; 197(1):257-63. PubMed ID: 17537444 [TBL] [Abstract][Full Text] [Related]
9. Slow coronary flow is associated with carotid artery dilatation. Yigit F; Sezgin AT; Demircan S; Tekin G; Erol T; Muderrisoglu H Tohoku J Exp Med; 2006 May; 209(1):41-8. PubMed ID: 16636521 [TBL] [Abstract][Full Text] [Related]
10. Plasma Choline as a Diagnostic Biomarker in Slow Coronary Flow. Zhu YT; Zhu LP; Wang ZY; Qiu XT; Wu WZ; Liu WW; Feng YY; Xiao WK; Luo X; Li ZY; Li CC Cardiol Res Pract; 2020; 2020():7361434. PubMed ID: 32411450 [TBL] [Abstract][Full Text] [Related]
11. Increased serum resistin levels in patients with coronary slow-flow phenomenon. Canga A; Cetin M; Kocaman SA; Durakoğlugil ME; Kırbaş A; Erdoğan T; Temiz A; Yılmaz A; Ciçek Y Herz; 2013 Nov; 38(7):773-8. PubMed ID: 23400345 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of coronary microvascular function and nitric oxide synthase intron 4a/b polymorphism in patients with coronary slow flow. Ekmekci A; Güngör B; Özcan KS; Abaci N; Ilhan E; Ekmekci SS; Kemaloğlu T; Osmonov D; Ustek D; Eren M Coron Artery Dis; 2013 Sep; 24(6):461-7. PubMed ID: 23811833 [TBL] [Abstract][Full Text] [Related]
13. Coronary artery ectasia is related to coronary slow flow and inflammatory activation. Brunetti ND; Salvemini G; Cuculo A; Ruggiero A; De Gennaro L; Gaglione A; Di Biase M Atherosclerosis; 2014 Apr; 233(2):636-640. PubMed ID: 24553454 [TBL] [Abstract][Full Text] [Related]
14. Increased neopterin levels and its association with angiographic variables in patients with slow coronary flow: an observational study. Varol E; Gülcan M; Aylak F; Ozaydın M; Sütçü R; Erdoğan D; Doğan A Anadolu Kardiyol Derg; 2011 Dec; 11(8):692-7. PubMed ID: 22088857 [TBL] [Abstract][Full Text] [Related]
15. Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow. Sen N; Ozlü MF; Başar N; Ozcan F; Güngör O; Turak O; Malçok O; Cağli K; Maden O; Erbay AR; Demir AD Turk Kardiyol Dern Ars; 2009 Apr; 37(3):168-73. PubMed ID: 19553739 [TBL] [Abstract][Full Text] [Related]
16. Relationship between HbA₁c and coronary flow rate in patients with type 2 diabetes mellitus and angiographically normal coronary arteries. Yılmaz MB; Erdem A; Yontar OC; Sarıkaya S; Yılmaz A; Madak N; Karadaş F; Tandoğan I Turk Kardiyol Dern Ars; 2010 Sep; 38(6):405-10. PubMed ID: 21200119 [TBL] [Abstract][Full Text] [Related]
17. Inverse correlation between coronary and retinal blood flows in patients with normal coronary arteries and slow coronary blood flow. Arbel Y; Sternfeld A; Barak A; Burgansky-Eliash Z; Halkin A; Berliner S; Herz I; Keren G; Rubinstein A; Banai S; Finkelstein A Atherosclerosis; 2014 Jan; 232(1):149-54. PubMed ID: 24401229 [TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 is increased in patients with slow coronary flow. Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814 [TBL] [Abstract][Full Text] [Related]
19. Impact of vitamin D insufficiency on the epicardial coronary flow velocity and endothelial function. Oz F; Cizgici AY; Oflaz H; Elitok A; Karaayvaz EB; Mercanoglu F; Bugra Z; Omer B; Adalet K; Oncul A Coron Artery Dis; 2013 Aug; 24(5):392-7. PubMed ID: 23695367 [TBL] [Abstract][Full Text] [Related]